Pfizer (NYSE:PFE) Coverage Initiated by Analysts at Guggenhe

Guggenheim initiated coverage on shares of Pfizer (NYSE:PFE – Free Report) in a research report sent to investors on Friday, Marketbeat Ratings reports. The firm issued a buy rating and a $36.00 target price on the biopharmaceutical company’s stock. Other equities analysts have also issued research reports about the stock. Cantor Fitzgerald reiterated an overweight […]

Related Keywords

Scott Gottlieb , Securities Exchange Commission , Pfizer , Pfizer Company Profile , Morgan Stanley , Charles Schwab Investment Management Inc , Pfizer Inc , Geode Capital Management , Cantor Fitzgerald , Barclays , Moneta Group Investment Advisors , Free Report , Marketbeat Ratings , Get Free Report , Director Scott Gottlieb , Exchange Commission , Street Corp , Group Investment Advisors , Capital Management , Schwab Investment Management , Pfizer Daily , Nyse Pfe , Pfe , Medical , 71708110 , Initiated Coverage , Guggenheim ,